South America Anti-Viral drugs Market Outlook - Market size, Segmentation, Market Share and Competitive Landscape (2016 - 2021)

  • ID: 3815061
  • Report
  • Region: America, South America
  • 94 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Abbott
  • Bristol-Myers-Squibb
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune/AstraZeneca
  • MORE
In the year 2015, the South America Anti-Viral drugs market was valued at USD XX Million. It is expected to increase to an estimated market value of USD XX Million while growing at a CAGR of XX.X% during the forecast period. Anti-Viral drugs are the drugs used to treat viral infections which can range from infections like flu to AIDS (Acquired Immuno Deficiency Syndrome). Just like common cold which is also caused by virus, most viral diseases are extremely difficult to cure and what the anti-viral drugs mostly do is slow down the reproduction of virus which in some cases enables immune system to eliminate the virus (as in case of flu) while slowing down the disease progression in other cases (as in case of AIDS).

The need of anti-viral drugs for patient's lifetime in case of diseases like HIV/AIDS along with well-established supply chain that facilitates easy procurement are driving the growth of this market. While the increasing use of generics along with lack of incentivization and lack of curative anti-viral drugs for indications like HIV/AIDS are hindering the growth of this market.

This market has been segmented on the basis of target disease into HIV/AIDS, Hepatitis, Herpes and Influenza. The market has also been segmented by type of anti-viral into IPR Protected and Generic.

Based on geography, this market has been segmented into Brazil, Argentina and Rest of South America.

Lack of broad spectrum anti-viral drugs is currently the huge unmet need in this market and presents a great opportunity to companies. While the negative impact of viral vaccines on the growth of anti-viral drugs market and increasing focus on prevention rather than cure of viral diseases are currently the challenges faced by this market.

There are several major players operating in this market and some of them include: Abbott, Bristol-Myers-Squibb, Gilead, GlaxoSmithKline, Johnson & Johnson, MedImmune/AstraZeneca, Merck & Co, Roche and Schering-Plough.

Key Deliverables in the Study

1. Market analysis for the South America Anti-Viral Drugs Market, with region specific assessments and competition analysis on South America and Country scales
2. Market definition along with the identification of key drivers and restraints
3. Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on South America and country scale
4. Extensively researched competitive landscape section with profiles of major companies along with their market shares
5. Identification and analysis of the macro and micro factors that affect the South America Anti-Viral Drugs market on both South America and country scales
6. A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
7. A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
8. Insights on the major countries in which this industry is blooming and to also identify the regions that are still untapped

Please note: As this product is updated at the time of order, dispatch will be 72 hours from the date the order and full payment is received.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Bristol-Myers-Squibb
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune/AstraZeneca
  • MORE
1. Introduction
  • Study deliverables
  • Market Definition
  • Sizing Units
  • Base Currency
  • Review and Forecast period
  • General Study Assumptions
  • Research Methodology
  • Introduction
  • Analysis Methodology
  • Econometric Forecast
  • Expert validation
  • Study Timeline
2. Executive Summary
  • Key Inferences
  • Market Overview and Industry Trends
  • Current Market Senario
3. Market Overview
  • New Developments
  • Porter's Five Forces
  • Bargaining Power of Suppliers
  • Bargaining Power of Consumers
  • Threat to new entrants
  • Threat to substitute products and services
  • Competitive Rivalry within the industry
  • Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
  • Market Drivers
  • Anti virals needed for patient's lifetime in case of diseases like HIV/AIDS
  • Well established supply chain facilitates easy procurement
  • Market Restraints
  • Increasing use of generics
  • Lack of incentivization
  • Lack of curative anti virals for indications like HIV/AIDS
4. Key Challenges
  • Market negatively impacted by growth of viral vaccines market
  • Increasing focus on prevention rather than cure of viral diseases
  • Current Opportunities in the Market
  • Lack of broad spectrum anti viral drugs
  • South America Antivirals Drugs Market, by Target Disease
  • HIV/AIDS
  • Hepatitis
  • Herpes
  • Influenza
  • South America Antivirals Drugs Market, by Type of Anti-Viral
  • IPR Protected
  • Generics
  • South America Antiviral Drugs Market, By Geography
  • Brazil
  • Argentina
  • Rest of South America
5. Competitive Landscape
  • Merger and acquisition analysis
  • New Product Launches
  • Agreements, Collaborations and Parterships
  • Key Vendor Analysis
  • Abbott
  • Bristol-Myers-Squibb
  • Gilead
  • GlaxoSmithKline
  • Johnson & Johnson
  • MedImmune/AstraZeneca
  • Merck & Co
  • Roche
  • Schering-Plough
  • Analyst Outlook for Investment Opportunities
  • Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Abbott
- Bristol-Myers-Squibb
- Gilead
- GlaxoSmithKline
- Johnson & Johnson
- MedImmune/AstraZeneca
- Merck & Co
- Roche
- Schering-Plough
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll